Loading quotes...
Forecast
The analysts' average price target is âŹ18.08 (+69.13%). The median is âŹ18.08 (+69.13%).
| Buy |
Â
16 |
| Hold |
Â
17 |
| Sell |
Â
4 |
News Go to news feed
Core Laboratories shareholders confirm directors and KPMG, approve executive compensation
At the shareholders' meeting in Houston, Harvey Klingensmith and Curtis Anastasio were re-elected as Class I directors. The selection of KPMG as the independent auditor for the fiscal year ending December 31, 2026, and the advisory approval of executive compensation were both adopted. More than 50% of the outstanding capital was represented. Core Laboratories also reported Q1 results that missed expectations, with EPS of $0.06 and revenue of $121.8 million. » More on de.investing.com
Core Laboratories stock plunges after disappointing Q1 numbers
Core Laboratories reported Q1 2026 EPS of $0.06 versus an expected $0.26 and revenue of $121.8 million, both well below analysts' expectations. The result, along with operational disruptions from geopolitical conflicts and weather-related issues, led to a decline in net income and a roughly 14.3% drop in after-hours trading to $17.30. Management points to ongoing risks, emphasizes investments in digital platforms like RAPID, and gives EPS targets of $0.15 for Q3 2026 and $0.20 for Q4 2026. » More on de.investing.com
Core Laboratories to release quarterly results for period ending 31 Dec 2025 on 4 Feb 2026, analysts expect slight earnings rise
Core Laboratories is expected to report on the quarter ended 31 Dec 2025 on 4 February 2026. On average, four analysts forecast earnings of $0.192 per share (prior year: $0.160) and revenue of $132.1 million (prior year: $129.2 million), an increase of 2.24 percent. For the fiscal year, analysts on average project EPS of $0.789 (prior year: $0.690) and annual revenue of $520.4 million (prior year: $523.9 million). » More on finanzen.net
Historical dividends Dividends
All dividend metrics All metricsFinancials
| (EUR) | Jun 2026 | |
|---|---|---|
| Revenue | 109.18M | 1.13% |
| Gross profit | 20.36M | 5.31% |
| Net profit | 5.22M | 42.17% |
| EBITDA | 11.37M | 40.91% |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | âŹ490.47M |
Number of shares | 46.1M |
52-week high/low | âŹ17.53 - âŹ8.43 |
Dividend yield | 0.24% |
Dividends TTM | âŹ0.0259 |
Next dividend | âŹ0.00863 |
Beta | 1.06 |
P/E ratio | 22.07 |
PEG ratio | -1.99 |
P/B ratio | 2.12 |
P/S ratio | 1.10 |
Company profile
Core Laboratories N.V. bietet Dienstleistungen und Produkte zur Beschreibung von LagerstĂ€tten und zur Produktionssteigerung fĂŒr die Ăl- und Gasindustrie in den Vereinigten Staaten, Kanada und international an. Das Unternehmen ist in den Segmenten LagerstĂ€ttenbeschreibung und Produktionsverbesserung tĂ€tig. Das Segment LagerstĂ€ttenbeschreibung umfasst die Charakterisierung von Gesteins-, FlĂŒssigkeits- und Gasproben, um die Produktion zu steigern und die Gewinnung von Ăl und Gas aus den LagerstĂ€tten der Kunden zu verbessern. Es bietet laborgestĂŒtzte Analyse- und Felddienstleistungen zur Charakterisierung der Eigenschaften von Rohöl und Ălprodukten sowie eigene und gemeinsame Industriestudien an. Das Segment Production Enhancement bietet Dienstleistungen und Produkte im Zusammenhang mit der Fertigstellung von Bohrlöchern, Perforationen, Stimulationen und der Produktion. Es bietet integrierte Diagnosedienste zur Bewertung und Ăberwachung der EffektivitĂ€t von BohrlochabschlĂŒssen und zur Entwicklung von Lösungen zur Verbesserung der EffektivitĂ€t von Projekten zur verbesserten Ălgewinnung. DarĂŒber hinaus vermarktet und verkauft das Unternehmen seine Produkte durch eine Kombination aus AuĂendienstmitarbeitern, technischen Seminaren, Fachmessen und Printwerbung sowie durch Vertriebspartner. Das Unternehmen ist in rund 50 LĂ€ndern tĂ€tig. Das Unternehmen wurde 1936 gegrĂŒndet und hat seinen Sitz in Amstelveen in den Niederlanden.
| Name | Core Laboratories |
| CEO | Lawrence V. Bruno |
| Headquarters | Houston,
tx Netherlands |
| Website | |
| Sector | Energy |
| Industry | Energy Equipment & Services |
| IPO | 09/21/1995 |
| Employees | 3,300 |
Ticker symbols
| Exchange | Symbol |
|---|---|
NYSE | CLB |
Amsterdam | CLB.AS |
DĂŒsseldorf | CEI.DU |
Frankfurt | CEI.F |
London | 0Q82.L |
SIX | CEI.SW |
Discover assets
Shareholders of Core Laboratories also invest in the following assets


